FDA Approves Gene-Altering Leukemia Drug – U.S. News & World Report
U.S. News & World Report |
FDA Approves Gene-Altering Leukemia Drug
U.S. News & World Report The Food and Drug Administration on Wednesday approved its first gene therapy drug in the United States that will treat childhood leukemia. Novartis drug Kymriah works by genetically modifying pediatric and young adult patients' blood cells to attack … |
